Hypermanganesemia with Dystonia Type 2: A Potentially Treatable Neurodegenerative Disorder: A Case Series in a Tertiary University Hospital.
Khalid A AlhasanWalaa AlshuaibiMuddathir H HamadSuha SalimDima Z JamjoomAqeela H AlhashimMalak Ali AlGhamdiAmal Y KentabFahad A BashiriPublished in: Children (Basel, Switzerland) (2022)
Early diagnosis and intervention with chelating agents, such as calcium disodium edetate, will help change the outcome in patients with hypermanganesemia with dystonia type 2. This finding highlights the importance of early diagnosis and treatment in improving the outcomes of patients with treatable neurodegenerative disorders.